Borgeson Blake
SEC CIK 1856094 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| RXRX | RECURSION PHARMACEUTICALS, INC. | Dir | 6.16M | — | $10.39M | 82 | 2021-07-01 | 2026-09-01 |
Most active insiders at RXRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Borgeson Blake | Dir | — | $4.10M |
| 2 | Gibson Christopher | Dir | — | $3.84M |
| 3 | Khan Najat | Chief R, D Commercial Off, Dir | — | $806.7K |
| 4 | Taylor Ben R | CFO | — | $157.7K |
| 5 | Bumpus Namandje | Dir | — | $28.1K |
| 6 | Michor Franziska | Dir | — | — |
| 7 | Hallett David | CSO | — | — |
| 8 | Dar Zavain | Dir | — | — |
| 9 | Li Dean Y | Dir | — | — |
| 10 | Sun Elaine D | Dir | — | — |
Transactions 82
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-02 18:01 | 2026-09-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $3.34 | -30.0K | 6.16M | -0.5% | -$100.2K |
| T | 2026-08-06 17:09 | 2026-08-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $3.25 | -30.0K | 6.19M | -0.5% | -$97.5K |
| T | 2026-07-09 18:04 | 2026-07-07 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $3.96 | -40.0K | 6.22M | -0.6% | -$158.5K |
| 2026-06-22 16:32 | 2026-06-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +88.4K | 6.26M | +1% | $0 | |
| T | 2026-06-04 17:04 | 2026-06-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $3.68 | -30.0K | 6.17M | -0.5% | -$110.4K |
| T | 2026-05-07 16:44 | 2026-05-05 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $3.52 | -30.0K | 6.20M | -0.5% | -$105.6K |
| T | 2026-04-08 16:58 | 2026-04-07 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $3.10 | -30.0K | 6.23M | -0.5% | -$93.0K |
| 2026-03-04 | 2026-03-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $3.46 | -170.0K | 6.26M | -3% | -$588.2K | |
| 2026-02-06 | 2026-02-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $4.20 | -220.0K | 6.43M | -3% | -$924.0K | |
| 2026-01-08 | 2026-01-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $4.36 | -220.0K | 6.65M | -3% | -$959.2K | |
| 2025-12-04 | 2025-12-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $4.37 | -220.0K | 6.87M | -3% | -$961.4K | |
| D | 2025-06-23 | 2025-06-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +22.0K | 7.09M | +0.3% | $0 |
| 2025-01-06 | 2025-01-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +1,734 | 7.07M | +0.0% | $0 | |
| 2024-11-14 | 2024-11-12 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.64 | -11.4K | 7.07M | -0.2% | -$87.5K | |
| 2024-10-31 | 2024-10-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.72 | -11.4K | 7.08M | -0.2% | -$76.9K | |
| 2024-10-17 | 2024-10-15 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.67 | -11.4K | 7.09M | -0.2% | -$76.4K | |
| 2024-10-04 | 2024-10-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +2,026 | 7.10M | +0.0% | $0 | |
| 2024-10-03 | 2024-10-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.22 | -11.4K | 7.10M | -0.2% | -$71.2K | |
| 2024-09-19 | 2024-09-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.84 | -11.4K | 7.11M | -0.2% | -$78.3K | |
| 2024-09-05 | 2024-09-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.27 | -11.4K | 7.12M | -0.2% | -$71.8K | |
| 2024-08-22 | 2024-08-20 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.12 | -11.4K | 7.13M | -0.2% | -$81.5K | |
| 2024-08-08 | 2024-08-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.82 | -11.4K | 7.14M | -0.2% | -$78.1K | |
| 2024-07-25 | 2024-07-23 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.48 | -11.4K | 7.16M | -0.2% | -$97.1K | |
| 2024-07-11 | 2024-07-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.32 | -11.4K | 7.17M | -0.2% | -$83.8K | |
| 2024-07-03 | 2024-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +1,441 | 7.18M | +0.0% | $0 | |
| 2024-06-27 | 2024-06-25 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $9.51 | -11.4K | 7.18M | -0.2% | -$108.9K | |
| 2024-06-13 | 2024-06-11 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.45 | -11.4K | 7.19M | -0.2% | -$96.7K | |
| D | 2024-06-05 | 2024-06-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +13.1K | 7.20M | +0.2% | $0 |
| 2024-05-30 | 2024-05-28 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $9.17 | -11.4K | 7.19M | -0.2% | -$105.0K | |
| 2024-05-16 | 2024-05-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $10.12 | -20.1K | 7.20M | -0.3% | -$202.9K | |
| 2024-05-02 | 2024-04-30 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.95 | -11.4K | 7.22M | -0.2% | -$91.0K | |
| 2024-04-18 | 2024-04-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.66 | -11.4K | 7.23M | -0.2% | -$87.7K | |
| 2024-04-03 | 2024-04-02 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.82 | -11.4K | 7.24M | -0.2% | -$101.0K | |
| 2024-03-21 | 2024-03-19 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $10.79 | -20.1K | 7.25M | -0.3% | -$216.4K | |
| 2024-03-07 | 2024-03-05 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $12.06 | -20.1K | 7.27M | -0.3% | -$241.9K | |
| M | 2024-02-21 | 2024-02-20 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $12.32 | -20.1K | 7.29M | -0.3% | -$247.1K |
| 2024-02-08 | 2024-02-06 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $9.30 | -11.4K | 7.31M | -0.2% | -$106.5K | |
| 2024-01-25 | 2024-01-23 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $10.58 | -20.1K | 7.32M | -0.3% | -$212.2K | |
| M | 2024-01-11 | 2024-01-09 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $13.62 | -20.1K | 7.36M | -0.3% | -$273.2K |
| 2023-12-28 | 2023-12-26 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $10.63 | -20.1K | 7.36M | -0.3% | -$213.2K | |
| 2023-12-14 | 2023-12-12 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.40 | -11.4K | 7.38M | -0.2% | -$84.7K | |
| 2023-11-30 | 2023-11-28 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.72 | -11.4K | 7.40M | -0.2% | -$76.9K | |
| 2023-11-16 | 2023-11-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.32 | -8,885 | 7.41M | -0.1% | -$56.2K | |
| 2023-11-02 | 2023-10-31 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $5.27 | -8,885 | 7.42M | -0.1% | -$46.8K | |
| 2023-10-19 | 2023-10-17 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.58 | -8,885 | 7.43M | -0.1% | -$58.5K | |
| 2023-10-05 | 2023-10-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.29 | -8,885 | 7.43M | -0.1% | -$64.8K | |
| 2023-09-21 | 2023-09-19 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.36 | -8,885 | 7.44M | -0.1% | -$74.3K | |
| 2023-09-07 | 2023-09-05 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.79 | -8,885 | 7.45M | -0.1% | -$78.1K | |
| 2023-08-24 | 2023-08-22 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.91 | -8,885 | 7.46M | -0.1% | -$79.2K | |
| M | 2023-08-10 | 2023-08-08 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $11.16 | -17.8K | 7.47M | -0.2% | -$198.4K |
| 2023-07-27 | 2023-06-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | G - Gift | $0.00 | -14.0K | 7.51M | -0.2% | $0 | |
| 2023-07-27 | 2023-07-25 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $14.61 | -18.7K | 7.49M | -0.2% | -$273.5K | |
| 2023-07-13 | 2023-07-11 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.89 | -8,885 | 7.52M | -0.1% | -$61.2K | |
| 2023-06-29 | 2023-06-27 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.39 | -8,885 | 7.53M | -0.1% | -$65.7K | |
| D | 2023-06-21 | 2023-06-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +12.6K | 7.54M | +0.2% | $0 |
| 2023-06-15 | 2023-06-13 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $9.98 | -15.5K | 7.53M | -0.2% | -$154.5K | |
| 2023-06-01 | 2023-05-30 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.79 | -8,885 | 7.54M | -0.1% | -$78.1K | |
| 2023-05-17 | 2023-05-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $5.09 | -8,885 | 7.55M | -0.1% | -$45.2K | |
| 2023-04-20 | 2023-04-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $5.93 | -8,885 | 7.56M | -0.1% | -$52.7K | |
| 2023-04-06 | 2023-04-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $6.53 | -8,885 | 7.57M | -0.1% | -$58.0K | |
| 2023-03-23 | 2023-03-21 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.40 | -8,885 | 7.58M | -0.1% | -$65.7K | |
| 2023-03-09 | 2023-03-07 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.33 | -8,885 | 7.59M | -0.1% | -$74.0K | |
| 2023-02-23 | 2023-02-21 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.73 | -8,885 | 7.59M | -0.1% | -$68.7K | |
| 2023-02-09 | 2023-02-07 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.81 | -8,885 | 7.60M | -0.1% | -$78.3K | |
| 2023-01-26 | 2023-01-24 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.71 | -8,885 | 7.61M | -0.1% | -$77.4K | |
| 2023-01-12 | 2023-01-10 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.69 | -8,885 | 7.62M | -0.1% | -$68.3K | |
| 2023-01-05 | 2023-01-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +1,325 | 7.63M | +0.0% | $0 | |
| 2022-12-29 | 2022-12-27 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $7.25 | -8,885 | 7.63M | -0.1% | -$64.4K | |
| 2022-12-15 | 2022-12-13 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.96 | -8,885 | 7.64M | -0.1% | -$79.6K | |
| 2022-12-01 | 2022-11-29 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $8.75 | -8,885 | 7.65M | -0.1% | -$77.7K | |
| 2022-11-18 | 2022-11-16 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $11.12 | -17.8K | 7.65M | -0.2% | -$197.6K | |
| 2022-10-05 | 2022-10-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Dir | A - Grant | $0.00 | +920 | 7.67M | +0.0% | $0 | ||
| 2022-07-06 | 2022-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +1,186 | 7.67M | +0.0% | $0 | |
| D | 2022-06-16 | 2022-06-14 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +18.1K | 7.67M | +0.2% | $0 |
| 2022-04-05 | 2022-04-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +1,300 | 7.65M | +0.0% | $0 | |
| 2022-01-05 | 2022-01-03 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +555 | 7.66M | +0.0% | $0 | |
| 2022-01-05 | 2022-01-04 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $18.03 | -9,625 | 7.65M | -0.1% | -$173.5K | |
| 2021-12-23 | 2021-12-21 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $18.75 | -9,625 | 7.66M | -0.1% | -$180.5K | |
| M | 2021-12-09 | 2021-12-07 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $20.31 | -9,625 | 7.68M | -0.1% | -$195.5K |
| M | 2021-11-22 | 2021-11-18 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | S - Sale | $18.91 | -9,625 | 7.68M | -0.1% | -$182.0K |
| 2021-10-05 | 2021-10-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +457 | 7.69M | +0.0% | $0 | |
| 2021-07-06 | 2021-07-01 | RXRX | RECURSION PHARMACEUTICALS, INC. | Borgeson Blake | Dir | A - Grant | $0.00 | +278 | 7.69M | +0.0% | $0 |
Purchase Sale Sale after option exercise All abbreviations